DAVE 241115 22.50P (DAVE241115P22500) Stock Options, News & Quotes

US OptionsDetailed Quotes

DAVE241115P22500

Watchlist

0.35
0.000.00%

15min DelayClose Oct 30 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Dave to Report Third Quarter 2024 Results on November 12, 2024 at 5:00 P.m. ET
GlobeNewswireOct 25 08:30 ET
Lake Street Maintains Dave Inc(DAVE.US) With Buy Rating, Maintains Target Price $53
Moomoo NewsOct 14 09:31 ET · Ratings
Dave Inc.: A Rising Small Cap Star in the Fintech Market
Yahoo FinanceOct 12 10:19 ET
Express News | JMP Securities Reiterates Market Outperform on Dave, Maintains $75 Price Target
BenzingaOct 9 14:06 ET
Dave Inc (DAVE) Q2 2024 Earnings Call Highlights: Record Revenue and Profitability Surge Amid ...
InvestingOct 9 11:03 ET
Critical Insights From Dave Analyst Ratings: What You Need To Know
BenzingaSep 26 15:00 ET · Ratings

Comments

Tonyco

Oct 17 16:59

$Dave Inc (DAVE.US)$
Buy the dip! My initial position is $34.3 but I added more at $37.83.
If the pullback gains power I want to add alot more next time.

Tonyco

Aug 5 15:24

Instead of panicking...

While the others take big losses selling everything they have, I feel the more rational decision is to do nothing.
The tech sector, specifically semiconductors and Ai/crypto companies, aren't going anywhere. NVDA isn't going to just shrug their shoulders and give up tomorrow.
So long as you have researched and relied on financials, I think it will all come back and probably stronger than ever.
In the meantime, I've added to a couple of "defense" stocks:
$ADMA Biologics (ADMA.US)$ : 58.8% U...

Chip stocks hit hard, intel's earnings disappoint: Still a good bet?

Tonyco

Jul 10 08:06

Today grabbing
$Dave Inc (DAVE.US)$
PT $41+ SL $27
$Desktop Metal (DM.US)$
LT PT: $17+
$Hims & Hers Health (HIMS.US)$
LT PT: $39.27+
$Intel (INTC.US)$
PT: $50 SL: $25
Medium duration, 14-30 days min.

Mars Mooo

May 1 04:18

Ten stocks with >300% YTD, Top 5 Gainers (30 Apr), and Quick Poll on the Fed interest rate decisions on 1 May 2024.

Hello Mooers!
A quick recap for the month ending April 30, 2024.
Ten stocks with >300% YTD
$Swvl Holdings (SWVL.US)$718.40%
$Root Inc (ROOT.US)$564.60%
$Elevation Oncology (ELEV.US)$561.08%
$JanOne (JAN.US)$554.05%
$GeneDx Holdings (WGS.US)$520.71%
$Corbus Pharmaceuticals (CRBP.US)$513.25%
$AGBA Group (AGBA.US)$482.90%
$Janux Therapeutics (JANX.US)$431.22%
$Dave Inc (DAVE.US)$4...

Moomoo AI

Feb 22 05:40

Despite strong revenue growth, Dave's low P/S ratio may indicate investor belief of underperformance in the broader industry. Shareholders may think recent performance has peaked, leading to lower selling prices. The low P/S ratio could signal price risks if medium-term revenue trends persist, but investors anticipate future revenue volatility.

Even With A 53% Surge, Cautious Investors Are Not Rewarding Dave Inc.'s (NASDAQ:DAVE) Performance Completely